U96-CAR-T-Cells For R/R B-ALL — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Relapsed or Refractory B Cell Leukemia and Lymphoma trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

China

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu

Key details

Phase

First-in-human testing

Sponsor

The First Affiliated Hospital of Soochow University

Enrollment target

~30 participants

Started

March 2026

Primary completion

January 2027

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

U96-CAR-T-Cells For R/R B-ALL — Stella